It's been quite the week for Blade Air Mobility Inc. NASDAQ: BLDE. On August 4, Blade and Joby Aviation Inc. NYSE: JOBY announced the sale of Blade's passenger mobility business to Joby for up to $125 million.
Blade Air Mobility sold its passenger/UAM division to Joby Aviation, shifting focus to medical organ transport and rebranding as Strata Critical Medical. The deal improves Blade's capital position but sacrifices the higher-growth air taxi opportunity, disappointing original investment expectations. Strata now controls 30% of the organ logistics market, with strong growth, solid profitability, and trades at an attractive valuation below 1x sales.
Blade Air Mobility, Inc. (NASDAQ:BLDE ) Q2 2025 Earnings Call August 5, 2025 8:00 AM ET Company Participants Mathew Schneider - Vice President of Investor Relations & Strategic Finance Melissa M. Tomkiel - President, General Counsel & Corporate Secretary Robert S.
Blade Air Mobility, Inc. (BLDE) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.06 per share a year ago.
Electric air taxi developer Joby Aviation has agreed to buy Blade Air Mobility's helicopter ride-share business for as much as $125 million.
Blade Air Mobility is well-positioned for the eVTOL-driven UAM market, with an asset-light model and multiple manufacturer partnerships. The Trump Executive Order accelerates eVTOL integration, but its immediate impact on Blade is limited beyond potential certification speed-up. Blade's current valuation is attractive, trading at just 1x EV/S, with significant upside once eVTOLs unlock the $1+ billion TAM.
Does Blade Air Mobility, Inc. (BLDE) have what it takes to be a top stock pick for momentum investors? Let's find out.
Blade Air Mobility (BLDE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Blade Mobility provides air transport alternatives with a fleet of helicopters, private jets, turboprops, and amphibious seaplanes. The company's business is divided into Medical Services and Passenger Services verticals.
Blade Air Mobility, Inc. (NASDAQ:BLDE ) Q1 2025 Earnings Conference Call May 12, 2025 8:00 AM ET Company Participants Matthew Schneider - VP, Investor Relations and Strategic Finance Robert Wiesenthal - Chief Executive Officer William Heyburn - Chief Financial Officer Conference Call Participants Jason Helfstein - Oppenheimer Lauren Lee - Deutsche Bank Bill Peterson - JPMorgan Jon R Hickman - Ladenburg Thalmann Ben Klieve - Lake Street Capital Markets Operator Good morning, ladies and gentlemen, and welcome to the Blade Air Mobility First Quarter 2025 Earnings Release Conference Call. At this time, all participants are in a listen-only mode.
Blade Air Mobility, Inc. (BLDE) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.06 per share a year ago.
Summary ⚈ Market conditions in May create opportunities for penny stock investors.⚈ Compass Therapeutics and Blade Air Mobility are highlighted for strong growth prospects.